Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP326848.RAS1Q2u2H2Rd_KYbnyjdn7VrHBGgDF-usudDK6NpKeoeU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP326848.RAS1Q2u2H2Rd_KYbnyjdn7VrHBGgDF-usudDK6NpKeoeU130_assertion type Assertion NP326848.RAS1Q2u2H2Rd_KYbnyjdn7VrHBGgDF-usudDK6NpKeoeU130_head.
- NP326848.RAS1Q2u2H2Rd_KYbnyjdn7VrHBGgDF-usudDK6NpKeoeU130_assertion description "[Within the placebo group, more CCA-IMT progression was found for smokers with the GSTM1-0 than for smokers with the GSTM1-1 genotype after adjustment for baseline IMT and major CVD risk factors (0.050 versus -0.002 mm, P=0.046).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326848.RAS1Q2u2H2Rd_KYbnyjdn7VrHBGgDF-usudDK6NpKeoeU130_provenance.
- NP326848.RAS1Q2u2H2Rd_KYbnyjdn7VrHBGgDF-usudDK6NpKeoeU130_assertion evidence source_evidence_literature NP326848.RAS1Q2u2H2Rd_KYbnyjdn7VrHBGgDF-usudDK6NpKeoeU130_provenance.
- NP326848.RAS1Q2u2H2Rd_KYbnyjdn7VrHBGgDF-usudDK6NpKeoeU130_assertion SIO_000772 11500195 NP326848.RAS1Q2u2H2Rd_KYbnyjdn7VrHBGgDF-usudDK6NpKeoeU130_provenance.
- NP326848.RAS1Q2u2H2Rd_KYbnyjdn7VrHBGgDF-usudDK6NpKeoeU130_assertion wasDerivedFrom befree-2016 NP326848.RAS1Q2u2H2Rd_KYbnyjdn7VrHBGgDF-usudDK6NpKeoeU130_provenance.
- NP326848.RAS1Q2u2H2Rd_KYbnyjdn7VrHBGgDF-usudDK6NpKeoeU130_assertion wasGeneratedBy ECO_0000203 NP326848.RAS1Q2u2H2Rd_KYbnyjdn7VrHBGgDF-usudDK6NpKeoeU130_provenance.